C-Type Lectin Receptors-Triggered Antifungal Immunity May Synergize with and Optimize the Effects of Immunotherapy in Hepatocellular Carcinoma
Jinkun Xia,Haoran Ding,Shujun Liu,Ran An,Xiaolei Shi,Ming Chen,Haozhen Ren
DOI: https://doi.org/10.2147/jir.s394503
IF: 4.5
2023-01-05
Journal of Inflammation Research
Abstract:Jinkun Xia, 1, 2, &ast Haoran Ding, 1, &ast Shujun Liu, 3 Ran An, 1, 2 Xiaolei Shi, 1– 3 Ming Chen, 1 Haozhen Ren 1– 3 1 Department of Hepatobiliary Surgery, The Affiliated Drum Tower Hospital, Medical School, Nanjing University, Nanjing, People's Republic of China; 2 Institute of Hepatobiliary Surgery, Medical School, Nanjing University, Nanjing, People's Republic of China; 3 Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, People's Republic of China &astThese authors contributed equally to this work Correspondence: Haozhen Ren; Ming Chen, Email ; Hepatocellular carcinoma (HCC) is one of the most common malignant tumors of the digestive system worldwide, and there is a lack of effective treatment for late-stage HCC. Recent experimental studies have demonstrated that dysfunction of the intestinal flora has a significant impact on hepatocarcinogenesis. The pathophysiological link between the intestine, its microbiota, and the liver has been described as the "gut-liver axis". Dysbiosis of the intestinal flora and increased permeability of the intestinal wall are closely associated with liver pathology through the immune response. The "gut-liver axis" theory has been applied to the clinical study of the pathogenesis and treatment of HCC. The intestinal fungal community, as part of the gut microbiome, has a significant impact on human health and disease, while relatively little research has been done in HCC. In this study, we performed a comprehensive analysis of the expression and potential biological functions of the fungal recognition receptors C-type lectin receptors (CLRs) (Dectin-1, Dectin-2, Dectin-3, and Mincle) in HCC. We found that CLRs were downregulated in HCC, and their expressions were correlated with the clinical prognosis of HCC patients. Further studies suggested that the expression of CLRs were significantly correlated with immune infiltration and immunotherapy efficacy in HCC. Based on previous studies and our findings, we hypothesize that intestinal fungal communities and CLRs-triggered antifungal immunity have a key role in the pathogenesis of HCC, and these findings may provide new perspectives and targets for HCC immunotherapy. Keywords: hepatocellular carcinoma, mycobiome, fungus, immunity, C-type lectin receptor, gut-liver axis Hepatocellular carcinoma (HCC) is the most common histologic type of liver cancer, accounting for approximately 80–90% of cases, and is the sixth most common cancer and the third leading cause of cancer-related deaths worldwide. 1 HCC often originates in the liver with chronic inflammation induced by diseases such as viral hepatitis and nonalcoholic steatohepatitis (NASH); thus, its microenvironmental composition is very complex and highly heterogeneous among patients. 2 Since the 5-year survival rate for liver cancer is only 18%, the search for additional new and effective treatments is ongoing. 3 Adverse events with conventional anti-HCC drugs have also raised concerns. 4 Recently, the treatment of HCC with immune checkpoint blockade (ICB) has shown promising efficacy and prolonged patient survival. 5 However, the high degree of tumor heterogeneity and the frequent emergence of immune resistance limit the benefit of immunotherapy, and as a consequence, most patients do not benefit from ICB therapy. 6,7 Therefore, understanding the mechanisms of immune regulation in the HCC microenvironment, identifying predictive biomarkers for checkpoint inhibitor-based immunotherapy, and developing new drug targets may improve the antitumor efficacy of immunotherapy. 8 The liver is the largest organ for anabolism and detoxification in the human body. On the one hand, nutrients from the intestine and metabolites of the intestinal microflora enter the liver through the blood into the portal system. 9 On the other hand, metabolic products from the liver flow into the intestine through the biliary system, which in turn affects the colonization environment of the intestinal flora. 9 This bidirectional enterohepatic exchange system consisting of the intestinal flora with the portal system and bile duct system is usually called the "gut-liver axis" and is the physiological basis of the interaction between the intestinal flora and the liver. 10 The intestinal flora is one of the focal points of emerging research in the field of HCC in recent years. Currently, the intestinal flora can be broadly classified into 3 types - beneficial, conditionally pathogenic and pathogenic, and most members of the intestinal flora, such as Bacteroidetes, Eubacterium, Bifidobacterium, Rumex -Abstract Truncated-
immunology